Individuals exposed to toxic PFAS chemicals found in firefighting foam may be eligible to seek compensation for cancer, long-term illness, and environmental exposure injuries.
The Aqueous Film-Forming Foam (AFFF) litigation involves thousands of lawsuits filed by firefighters, military personnel, airport workers, and civilians who were exposed to PFAS chemicals contained in firefighting foam products. PFAS substances are commonly known as “forever chemicals” because they do not naturally degrade and can accumulate in the human body over time.
Plaintiffs allege that manufacturers produced and sold AFFF despite decades of internal research suggesting potential health dangers. Lawsuits claim companies failed to warn users about cancer risks and environmental contamination.
These claims are consolidated into federal multidistrict litigation (MDL), allowing courts to evaluate shared scientific evidence while preserving individual injury claims.
AFFF foam has been widely used since the 1960s to suppress fuel-based fires, especially at military bases, airports, and industrial facilities. The foam contains PFAS compounds such as PFOS and PFOA, which resist heat, oil, and water but persist indefinitely in soil and groundwater.
Repeated training exercises and emergency deployments allegedly released large quantities of PFAS into surrounding environments, contaminating drinking water supplies and exposing nearby communities.
Because PFAS chemicals bioaccumulate, even low-level exposure over long periods may increase health risks.
Scientific studies reviewed during federal litigation have examined connections between PFAS exposure and serious medical conditions. Researchers have evaluated links to cancer development, immune system suppression, thyroid dysfunction, and metabolic disorders.
Expert testimony presented in court proceedings analyzes decades of toxicology data, occupational exposure studies, and environmental monitoring results to determine whether manufacturers adequately tested product safety.
These scientific findings play a central role in determining liability and potential settlement outcomes.
Frequently cited in PFAS exposure studies and firefighter claims.
Associated with long-term occupational exposure.
Hormonal disruption linked to PFAS accumulation.
Inflammatory bowel disease examined in PFAS research.
Reduced immune response observed in exposure studies.
Under investigation in ongoing litigation.
You may qualify if you were exposed to AFFF firefighting foam and later developed a qualifying medical condition.
Exposure during training or emergency response.
Service at contaminated bases or airfields.
Exposure through contaminated drinking water.
The AFFF litigation represents one of the largest environmental mass torts in U.S. history, involving tens of thousands of plaintiffs. Cases are coordinated in federal multidistrict litigation to streamline discovery and expert testimony.
Several manufacturers have entered large settlement agreements related to PFAS contamination claims, while additional cases continue toward trial and negotiated resolutions.
Compensation varies depending on medical diagnosis, exposure history, and individual damages.
No. Claims are handled on a contingency basis, meaning you do not pay out-of-pocket fees. Legal costs are deducted only from a successful settlement.
Mass tort cases may take months or years depending on court schedules, scientific review, and settlement negotiations.
Yes. Each plaintiff maintains an individual claim while benefiting from shared evidence presented in the mass tort litigation.
Submit your information for a free case evaluation. You pay nothing unless compensation is recovered.
Start Free Case Review